Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8132712 | NORTON WATERFORD | Metered-dose inhaler |
Sep, 2028
(4 years from now) | |
US11395889 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US10086156 | NORTON WATERFORD | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
US10022509 | NORTON WATERFORD | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
US10695512 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US10022510 | NORTON WATERFORD | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US8931476 | NORTON WATERFORD | Inhaler |
Jul, 2031
(7 years from now) | |
US10561808 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
US11395888 | NORTON WATERFORD | Inhalers and related methods |
Jan, 2038
(14 years from now) | |
US10792447 | NORTON WATERFORD | Breath actuated inhaler |
Jan, 2039
(15 years from now) | |
US11559637 | NORTON WATERFORD | Inhalers and related methods |
Jul, 2039
(15 years from now) | |
US11583643 | NORTON WATERFORD | Inhalers and related methods |
Aug, 2041
(17 years from now) |
Qvar Redihaler is owned by Norton Waterford.
Qvar Redihaler contains Beclomethasone Dipropionate.
Qvar Redihaler has a total of 12 drug patents out of which 0 drug patents have expired.
Qvar Redihaler was authorised for market use on 03 August, 2017.
Qvar Redihaler is available in aerosol, metered;inhalation dosage forms.
The generics of Qvar Redihaler are possible to be released after 19 August, 2041.
Drugs and Companies using BECLOMETHASONE DIPROPIONATE ingredient
Market Authorisation Date: 03 August, 2017
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic